Participation of 5-HT1-like and 5-HT2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs

被引:27
作者
Verheggen, R
Freudenthaler, S
MeyerDulheuer, F
Kaumann, AJ
机构
[1] BABRAHAM INST, DEPT NEUROBIOL, HUMAN PHARMACOL LAB, CAMBRIDGE CB2 4AT, ENGLAND
[2] UNIV GOTTINGEN, DEPT NEUROSURG, D-37075 GOTTINGEN, GERMANY
关键词
contraction of human temporal artery; 5-HT2A and 5-HT1-like receptors; endothelium; sumatriptan; SK&F 103829; 5-hydroxytryptamine;
D O I
10.1111/j.1476-5381.1996.tb15188.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 We investigated the hypothesis that, as in some other large human arteries, 5-HT-induced contraction of the temporal artery is mediated through two co-existing receptor populations, 5-HT1-like-and 5-HT(2)A. Temporal arterial segments were obtained from patients undergoing brain surgery and rings prepared set up to contract with 5-HT and related agents. Fractions of maximal 5-HT responses mediated through 5-HT1-like and 5-HT2A receptors, f(1) and f(2) = 1-f(1), were estimated by use of the 5-HT2A-selective antagonist ketanserin. 2 In rings with intact endothelium 5-HT evoked contractions with a -log EC50, M of 7.0. Ketanserin (10-1000 nM) antagonized part of the 5-HT-induced contractions. Ketanserin-resistant components of 5-HT-induced contractions were found with -log EC50, M of 6.9 and f(1) of 0.17 (100 nM ketanserin) and log EC50, M of 6.4 and f(1) of 0.20 (1000 nM ketanserin). 3 In rings with endothelial function attenuated by enzymatic treatment, 5-HT caused contractions with a -log EC50, M of 7.2 that were partially blocked by ketanserin. Ketanserin-resistant components of 5-HT-induced contractions were found with -log EC50, M 7.4 and f(1) of 0.16 (100 nM ketanserin) and -log EC50, M of 7.5 and f(1) of 0.14 (1000 nM ketanserin). 4 The ketanserin-resistant component of 5-HT-evoked contraction was blocked by methiothepin (100-1000 nM) consistent with mediation through 5-HT1-like receptors. 5 In rings with intact endothelium the 5-HT1-like-selective agonist, sumatriptan, caused small contractions with a -log EC50, M of 6.5 and intrinsic activity of 0.21 with respect to 5-HT that were resistant to blockade by 1000 nM ketanserin but antagonized by 100 nM methiothepin. 6 In rings with intact endothelium the 5-HT2A receptor partial agonist SK&F 103829 (2,3,4,5-tetrahydro-8[methyl sulphonyl]-1H3-benzazepin-7-ol methensulphonate) contracted rings with a -log EC50, M of 5.0 and an intrinsic activity of 0.49 with respect to 5-HT; the effects were antagonized by ketanserin 1000 nM. 7 We conclude that 80-86% of the maximum 5-HT-evoked contraction of human temporal artery is mediated through 5-HT(2)A receptors, the remainder through 5-HT1-like-receptors, regardless of whether or not endothelium is functional. The 5-HT1-like-receptor are more likely to be 5-HT1D beta receptors than 5-HT1D alpha receptors and sumatriptan is a full agonist for these receptors. As found in arteries of other species, SK&F 103829 is a partial agonist for 5-HT(2)A receptors of human temporal artery.
引用
收藏
页码:283 / 292
页数:10
相关论文
共 50 条
  • [41] SUMATRIPTAN CONTRACTS LARGE CORONARY-ARTERIES OF BEAGLE DOGS THROUGH 5-HT1-LIKE RECEPTORS
    PARSONS, AA
    STUTCHBURY, C
    RAVAL, P
    KAUMANN, AJ
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1992, 346 (05) : 592 - 596
  • [42] Functional expression of 5-HT2A receptors in mouse osteoblasts. -: Activation of ERK pathway by 5-HT2A receptors on osteoblastic cell proliferation
    Hirai, Takao
    Yoshinaga, Naoko
    Kurosaki, Teruko
    Nishio, Hiroaki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 101 : 65 - 65
  • [43] Regulation of sensitivity to 5-hydroxytryptamine in pulmonary supernumerary but not conventional arteries by a 5-HT1D-like receptor
    Shaw, AM
    Bunton, DC
    Brown, T
    Irvine, J
    MacDonald, A
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 408 (01) : 69 - 82
  • [44] ROLE OF 5-HT2 RECEPTORS IN SEROTONIN-INDUCED CONTRACTION IN THE HUMAN MAMMARY ARTERY
    CONTI, A
    MONOPOLI, A
    FORLANI, A
    ONGINI, E
    ANTONA, C
    BIGLIOLI, P
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 176 (02) : 207 - 212
  • [45] SUMATRIPTAN IS A POTENT VASOCONSTRICTOR OF HUMAN DURAL ARTERIES VIA A 5-HT1-LIKE RECEPTOR
    JANSEN, I
    EDVINSSON, L
    MORTENSEN, A
    OLESEN, J
    CEPHALALGIA, 1992, 12 (04) : 202 - 205
  • [46] Flesinoxan dose-dependently reduces extracellular 5-hydroxytryptamine (5-HT) in rat median raphe and dorsal hippocampus through activation of 5-HT1A receptors
    Bosker, FJ
    deWinter, TYCE
    Klompmakers, AA
    Westenberg, HGM
    JOURNAL OF NEUROCHEMISTRY, 1996, 66 (06) : 2546 - 2555
  • [47] 5-hydroxytryptamine level and 5-HT2A receptor mRNA expression in the guinea pigs eyes with spectacle lens-induced myopia
    Yang, Ji-Wen
    Xu, Yan-Chun
    Sun, Lin
    Tian, Xiao-Dan
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2010, 3 (04) : 299 - 303
  • [48] Postsynaptic 5-HT1A receptors mediate 5-hydroxytryptamine release in the amygdala through a feedback to the caudal linear raphe
    Bosker, FJ
    Klompmakers, A
    Westenberg, HGM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 333 (2-3) : 147 - 157
  • [49] Ayahuasca-enhanced extinction of fear behaviour: Role of infralimbic cortex 5-HT2A and 5-HT1A receptors
    Werle, Isabel
    Nascimento, Laura M. M.
    dos Santos, Aymee L. A.
    Soares, Luciane A.
    dos Santos, Rafael G.
    Hallak, Jaime E. C.
    Bertoglio, Leandro J.
    BRITISH JOURNAL OF PHARMACOLOGY, 2024, 181 (11) : 1671 - 1689
  • [50] Acceleration of gastrointestinal transit by momordin Ic in mice:: possible involvement of 5-hydroxytryptamine, 5-HT2 receptors and prostaglandins
    Li, YH
    Matsuda, H
    Yamahara, J
    Yoshikawa, M
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 392 (1-2) : 71 - 77